Diabetes Care, Vol 23, Issue 1 70-73, Copyright © 2000 by American Diabetes Association

ARTICLES

Sulfonylurea receptor 1 gene variants are associated with gestational diabetes and type 2 diabetes but not with altered secretion of insulin

J Rissanen, A Markkanen, P Karkkainen, J Pihlajamaki, P Kekalainen, L Mykkanen, J Kuusisto, P Karhapaa, L Niskanen and M Laakso
Department of Medicine, University of Kuopio, Finland.

OBJECTIVE: To investigate the possible association of the variants in the nucleotide binding fold regions of the sulfonylurea receptor 1 (SUR1) gene with gestational diabetes mellitus (GDM), type 2 diabetes, and altered insulin secretion in Finnish subjects. RESEARCH DESIGN AND METHODS: The nucleotide binding fold regions of the SUR1 gene were amplified with polymerase chain reaction and screened by the single-strand conformational polymorphism analysis in 42 subjects with GDM and 40 subjects with type 2 diabetes. Detected variants were further investigated in 377 normoglycemic subjects by restriction fragment-length polymorphism analysis. The effect of the variants of the SUR1 gene on first-phase insulin secretion was studied in 295 normoglycemic subjects. RESULTS: In subjects with GDM or type 2 diabetes, one amino acid change (S1369A), four silent substitutions (R1273R, L829L, T759T, and K649K), and three intron variants were identified in the nucleotide binding fold regions of the SUR1 gene. A tagGCC allele of exon 16 splice acceptor site was more frequent in subjects with GDM (0.55 allele frequency, n = 42) and type 2 diabetes (0.60, n = 40) than in normoglycemic subjects (0.43, n = 377) (P1 = 0.024 and P2 = 0.009, respectively). Similarly, an AGG allele of the R1273R polymorphism was more common in subjects with GDM (0.87) and type 2 diabetes (0.87) than in normoglycemic subjects (0.74) (P1 = 0.009 and P2 = 0.001, respectively). However, the S1369A, R1273R, and cagGCC-->tagGCC variants of the SUR1 gene were not associated with altered first-phase insulin secretion in 295 normoglycemic subjects. CONCLUSIONS: These results suggest that a functional variant that contributes to the risk of GDM and type 2 diabetes may locate close to the SUR1 gene.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				Y. Feng, G. Mao, X. Ren, H. Xing, G. Tang, Q. Li, X. Li, L. Sun, J. Yang, W. Ma, et al. Ser1369Ala Variant in Sulfonylurea Receptor Gene ABCC8 Is Associated With Antidiabetic Efficacy of Gliclazide in Chinese Type 2 Diabetic Patients Diabetes Care, October 1, 2008; 31(10): 1939 - 1944. [Abstract] [Full Text] [PDF]

				T. O. Kilpelainen, T. A. Lakka, D. E. Laaksonen, O. Laukkanen, J. Lindstrom, J. G. Eriksson, T. T. Valle, H. Hamalainen, S. Aunola, P. Ilanne-Parikka, et al. Physical activity modifies the effect of SNPs in the SLC2A2 (GLUT2) and ABCC8 (SUR1) genes on the risk of developing type 2 diabetes Physiol Genomics, October 19, 2007; 31(2): 264 - 272. [Abstract] [Full Text] [PDF]

				T. A. Buchanan, A. Xiang, S. L. Kjos, and R. Watanabe What Is Gestational Diabetes? Diabetes Care, July 1, 2007; 30(Supplement_2): S105 - S111. [Full Text] [PDF]

				N. Yokoi, M. Kanamori, Y. Horikawa, J. Takeda, T. Sanke, H. Furuta, K. Nanjo, H. Mori, M. Kasuga, K. Hara, et al. Association Studies of Variants in the Genes Involved in Pancreatic {beta}-Cell Function in Type 2 Diabetes in Japanese Subjects. Diabetes, August 1, 2006; 55(8): 2379 - 2386. [Abstract] [Full Text] [PDF]

				S. K. Hansen, E.-M. D. Nielsen, J. Ek, G. Andersen, C. Glumer, B. Carstensen, P. Mouritzen, T. Drivsholm, K. Borch-Johnsen, T. Jorgensen, et al. Analysis of Separate and Combined Effects of Common Variation in KCNJ11 and PPARG on Risk of Type 2 Diabetes J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3629 - 3637. [Abstract] [Full Text] [PDF]

				O. Laukkanen, J. Pihlajamaki, J. Lindstrom, J. Eriksson, T. T. Valle, H. Hamalainen, P. Ilanne-Parikka, S. Keinanen-Kiukaanniemi, J. Tuomilehto, M. Uusitupa, et al. Polymorphisms of the SUR1 (ABCC8) and Kir6.2 (KCNJ11) Genes Predict the Conversion from Impaired Glucose Tolerance to Type 2 Diabetes. The Finnish Diabetes Prevention Study J. Clin. Endocrinol. Metab., December 1, 2004; 89(12): 6286 - 6290. [Abstract] [Full Text] [PDF]

				E J Parra, C J Hoggart, C Bonilla, S Dios, J M Norris, J A Marshall, R F Hamman, R E Ferrell, P M McKeigue, and M D Shriver Relation of type 2 diabetes to individual admixture and candidate gene polymorphisms in the Hispanic American population of San Luis Valley, Colorado J. Med. Genet., November 1, 2004; 41(11): e116 - e116. [Full Text] [PDF]

				J. C. Florez, N. Burtt, P. I.W. de Bakker, P. Almgren, T. Tuomi, J. Holmkvist, D. Gaudet, T. J. Hudson, S. F. Schaffner, M. J. Daly, et al. Haplotype Structure and Genotype-Phenotype Correlations of the Sulfonylurea Receptor and the Islet ATP-Sensitive Potassium Channel Gene Region Diabetes, May 1, 2004; 53(5): 1360 - 1368. [Abstract] [Full Text] [PDF]

				A. L. Gloyn, M. N. Weedon, K. R. Owen, M. J. Turner, B. A. Knight, G. Hitman, M. Walker, J. C. Levy, M. Sampson, S. Halford, et al. Large-Scale Association Studies of Variants in Genes Encoding the Pancreatic {beta}-Cell KATP Channel Subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) Confirm That the KCNJ11 E23K Variant Is Associated With Type 2 Diabetes Diabetes, February 1, 2003; 52(2): 568 - 572. [Abstract] [Full Text] [PDF]

				C. G. Nichols and J. C. Koster Diabetes and insulin secretion: whither KATP? Am J Physiol Endocrinol Metab, September 1, 2002; 283(3): E403 - E412. [Abstract] [Full Text] [PDF]

				S. Maier and A. Olek Diabetes: A Candidate Disease for Efficient DNA Methylation Profiling J. Nutr., August 1, 2002; 132(8): 2440S - 2443. [Abstract] [Full Text] [PDF]